Martin Shkreli’s 2022 release conditions bar him from participating in the pharmaceutical industry, including ownership stakes or business decisionsThe Federal Trade Commission (FTC) and seven US states have alleged that pharmaceutical executive Martin Shkreli repeatedly violated a lifetime ban on participating in the pharmaceutical industry, and …
FTC and seven states seek contempt ruling against Shkreli over pharma ban
Martin Shkreli’s 2022 release conditions bar him from participating in the pharmaceutical industry, including ownership stakes or business decisionsThe Federal Trade Commission (FTC) and seven US states have alleged that pharmaceutical executive Martin Shkreli repeatedly violated a lifetime ban on participating in the pharmaceutical industry, and …
Originally reported by The Guardian Business
More like this
All Business
Saudi national charged with secretly planting recording device in OpenAI office
Prosecutors say the device, wrapped in toilet paper, was found inserted in a USB port on the back of a TV in an execut…
BBC asks judge to force Trump to sit for deposition as part of his $10bn lawsuit
BBC asks US federal judge to compel Trump’s lawyers to schedule deposition after his team canceled initial sessionThe …
NI company in talks to save Poundland from administration
Poundland says Martin Property Group from Londonderry is the management team's "preferred partner"